Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.81 USD | +0.35% | +2.42% | -9.09% |
05-07 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
05-01 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.09% | 927M | |
+17.57% | 8.44B | |
+3.57% | 7.47B | |
+5.65% | 6.31B | |
-5.39% | 3.77B | |
-2.14% | 1.33B | |
-28.67% | 1.09B | |
+15.61% | 988M | |
-16.92% | 801M | |
-17.03% | 733M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- (USNA) USANA HEALTH SCIENCES Expects Fiscal Year 2024 Revenue Range $850M - $920M